Mineralys Therapeutics, Inc. MLYS
CIK 0001933414
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $98.52M
- Sold
- $99.61M
Sep 1, 2023 – Aug 25, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Sale10b5-1 footnote | $75.40K 5,026 shares sold | 3.44% sold Direct holding | ▾ |
| 2024-11-06 | Rodman David Malcom Chief Medical Officer | Sale10b5-1 footnote | $383.07K 25,482 shares sold | 15.78% sold Direct holding | ▾ |
| 2024-10-11 | Levy Adam Scott CFO and Secretary | Sale10b5-1 footnote | $146.00K 10,757 shares sold | 4.34% sold Direct holding | ▾ |
| 2024-10-11 | Congleton Jon Chief Executive Officer · Director | Sale10b5-1 footnote | $206.43K 15,271 shares sold | 1.68% sold Direct holding | ▾ |
| 2024-07-24 | Catalys Pacific Fund, LP · Slingsby Brian Taylor 10% owner | Sale | $7.18M 550,000 shares sold | Unavailable Indirect holding | ▾ |
| 2024-07-16 | Rodman David Malcom Chief Medical Officer | Sale10b5-1 footnote | $7.88K 525 shares sold | 0.51% sold Direct holding | ▾ |
| 2024-07-11 | Levy Adam Scott CFO and Secretary | Sale10b5-1 footnote | $141.39K 10,757 shares sold | 4.16% sold Direct holding | ▾ |
| 2024-07-11 | Congleton Jon Chief Executive Officer · Director | Sale10b5-1 footnote | $210.08K 15,746 shares sold | 1.70% sold Direct holding | ▾ |
| 2024-06-20 | Congleton Jon Chief Executive Officer · Director | Sale10b5-1 footnote | $175.24K 14,940 shares sold | 1.59% sold Direct holding | ▾ |
| 2024-06-18 | Congleton Jon Chief Executive Officer · Director | Sale10b5-1 footnote | $199.07K 16,607 shares sold | 1.73% sold Direct holding | ▾ |
Showing 17 / 17 record groups in 2024. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 17 of 17 purchase / sale groups and 30 of 64 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"MLYS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.